Ochratoxin A and human health risk: a review of the evidence

scientific article

Ochratoxin A and human health risk: a review of the evidence is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/10408398.2012.724480
P932PMC publication ID4247821
P698PubMed publication ID24874522

P2093author name stringFelicia Wu
Travis R Bui-Klimke
P2860cites workAristolochic acid and the etiology of endemic (Balkan) nephropathyQ24678244
Risk Assessment in the Federal GovernmentQ27025366
The changing profile of acute tubulointerstitial nephritisQ28191063
Ochratoxin A: the continuing enigmaQ28237697
Balkan endemic nephropathy: role of ochratoxins A through biomarkersQ28241625
Estimation of ochratoxin A in portuguese population: new data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection.Q31047174
Immunomodulation by fungal toxinsQ33931171
Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessmentQ33969253
Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxinsQ34521712
Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies)Q34532920
Ochratoxin a in Portugal: a review to assess human exposureQ35155861
A review of recent advances in understanding ochratoxicosisQ35636810
A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure modelQ35847068
Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysisQ36030952
Health risk assessment of ochratoxin A for all age-sex strata in a market economyQ36326356
Biomarkers of human exposure to ochratoxin A.Q36333069
Human ochratoxin a biomarkers--from exposure to effect.Q37852708
Risk assessment of the mycotoxin ochratoxin A.Q38754602
Ochratoxin a and human chronic nephropathy in Tunisia: is the situation endemic?Q38857033
Ochratoxin A and beta2-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the centre of Tunisia: a hot spot of Ochratoxin A exposureQ39054812
Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in TunisiaQ39198691
Relation between endemic (Balkan) nephropathy and urinary-tract tumoursQ39419449
Balkan (endemic) nephropathy and a toxin-producing strain of Penicillium verrucosum var cyclopium: An experimental model in ratsQ39428920
Human ochratoxicosis and nephropathy in Egypt: a preliminary studyQ39567391
Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxinQ39916509
Health risk assessment of the mycotoxin ochratoxin A to humans: Czech Republic--Brno--1991/92.Q40657151
High-performance liquid chromatographic determination of ochratoxin A and its 4R-4-hydroxy metabolite in human urine.Q41227100
Mode of formation of ochratoxin A.Q41277980
Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humansQ42639717
Quantitative determination of mycotoxins in urine by LC-MS/MSQ42917203
Urine ochratoxin a and sphinganine/sphingosine ratio in residents of the endemic nephropathy area in CroatiaQ43198600
Ochratoxin A and its metabolite ochratoxin alpha in urine and assessment of the exposure of inhabitants of Lleida, Spain.Q43893289
Evidence for an enterohepatic circulation of ochratoxin A in miceQ44701162
Serum levels of ochratoxin A in healthy adults in Tuscany: correlation with individual characteristics and between repeat measurementsQ44818943
Fungal toxins and Balkan (endemic) nephropathyQ45056957
Simultaneous LC-MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, α and β-zearalenols and fumonisin B1 in urine as a multi-biomarker method to assess exposure to mycotoxinsQ45206156
Seasonal variation in exposure frequency and concentration levels of aflatoxins and ochratoxins in urine samples of boys and girlsQ46668742
The dialysis of Ochratoxin A (OTA).Q47736086
Ochratoxin A in Danish cereals 1986-1992 and daily intake by the Danish population.Q50559278
Effect of organic synthetic food colours on mitochondrial respiration.Q50754907
Ochratoxin A exposure assessment of the inhabitants of Lisbon during winter 2007/2008 through bread and urine analysis.Q51612285
Monitoring of ochratoxin A exposure of the Portuguese population through a nationwide urine survey — Winter 2007Q58778345
Rapid mycotoxin analysis in human urine: A pilot studyQ59166926
Ochratoxin A-induced mycotoxic porcine nephropathy: alterations in enzyme activity in tubular cellsQ66918884
Toxicokinetics of ochratoxin A in several species and its plasma-binding propertiesQ69600911
Evaluation of certain food additives and contaminants. Thirty-seventh report of the Joint FAO/WHO Expert Committee on Food AdditivesQ70166081
Karyomegalic interstitial nephritisQ70856867
Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disordersQ72128275
Ochratoxin A in human sera in the area with endemic nephropathy in CroatiaQ73398833
Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disordersQ73781455
Detailed mapping of ochratoxin A reabsorption along the rat nephron in vivo: the nephrotoxin can be reabsorbed in all nephron segments by different mechanismsQ74761408
Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samplesQ77401292
Rapid method for the determination of ochratoxin A in urine by immunoaffinity column clean-up and high-performance liquid chromatographyQ77401372
Evaluation of certain mycotoxins in food. Fifty-sixth report of the Joint FAO/WHO Expert Committee on Food AdditivesQ77989837
Analysis of ochratoxin A in foods consumed by inhabitants from an area with balkan endemic nephropathy: a 1 month follow-up studyQ79917516
Evaluation of certain food additives and contaminantsQ80770375
Ochratoxin A in the morning and afternoon portions of urine from Coimbra and Valencian populationsQ81106045
Ochratoxin a content of urine samples of healthy humans in HungaryQ81555468
P433issue13
P407language of work or nameEnglishQ1860
P304page(s)1860-1869
P577publication date2015-01-01
P1433published inCritical Reviews in Food Science and NutritionQ15716669
P1476titleOchratoxin A and human health risk: a review of the evidence
P478volume55

Reverse relations

cites work (P2860)
Q41971473A Rapid Magnetic Solid Phase Extraction Method Followed by Liquid Chromatography-Tandem Mass Spectrometry Analysis for the Determination of Mycotoxins in Cereals
Q33611984A Review: Epigenetic Mechanism in Ochratoxin A Toxicity Studies
Q90394938A comparison between the effects of ochratoxin A and aristolochic acid on the inflammation and oxidative stress in the liver and kidney of weanling piglets
Q39045003A risk assessment of dietary Ochratoxin a in the United States
Q89576372Advances in Biodetoxification of Ochratoxin A-A Review of the Past Five Decades
Q61807176Antimicrobial Activity of Essential Oil of DC (Asteraceae) Aerial Parts at Flowering Period
Q91650984Aristolochic Acid-Induced Genotoxicity and Toxicogenomic Changes in Rodents
Q92422644Association of SOD2 (rs4880) and GPX1 (rs1050450) Gene Polymorphisms with Risk of Balkan Endemic Nephropathy and its Related Tumors
Q58769923Contaminants in Grain-A Major Risk for Whole Grain Safety?
Q58116453Current Status and Future Opportunities of Omics Tools in Mycotoxin Research
Q92350792Degrading Ochratoxin A and Zearalenone Mycotoxins Using a Multifunctional Recombinant Enzyme
Q47094501Determination of Ochratoxin A in Rye and Rye-Based Products by Fluorescence Polarization Immunoassay
Q58798609Development of a Magnetic Nanoparticles-Based Screen-Printed Electrodes (MNPs-SPEs) Biosensor for the Quantification of Ochratoxin A in Cereal and Feed Samples
Q52319722Electrochemical Aptamer-Based Sensors for Rapid Point-of-Use Monitoring of the Mycotoxin Ochratoxin A Directly in a Food Stream.
Q34353066Evaluating weight of evidence in the mystery of Balkan endemic nephropathy
Q91993884Health Benefits of Resveratrol in Kidney Disease: Evidence from In Vitro and In Vivo Studies
Q93140957Heterologous Expression and Characterization of A Novel Ochratoxin A Degrading Enzyme, N-acyl-L-amino Acid Amidohydrolase, from Alcaligenes faecalis
Q97423420Inhibitory effect of C. zeylanicum, C. longa, O. basilicum, Z. officinale, and C. martini essential oils on growth and ochratoxin A content of A. ochraceous and P. verrucosum in maize grains
Q33612089Initial Spore Density Has an Influence on Ochratoxin A Content in Aspergillus ochraceus CGMCC 3.4412 in PDB and Its Interaction with Seeds
Q55100911Label-Free QCM Immunosensor for the Detection of Ochratoxin A.
Q52656992Mycotoxin: Its Impact on Gut Health and Microbiota.
Q59794103Nanobody-Alkaline Phosphatase Fusion Protein-Based Enzyme-Linked Immunosorbent Assay for One-Step Detection of Ochratoxin A in Rice
Q48174111Ochratoxin A cytotoxicity on Madin-Darby canine kidney cells in the presence of alpha-tocopherol: Effects on cell viability and tight junctions
Q89523545Ochratoxin A in human blood plasma samples from apparently healthy volunteers in Nanjing, China
Q54574162Quantification of mycotoxins in vegetable oil by UPLC-MS/MS after magnetic solid-phase extraction.
Q40361733Recombinant Mitochondrial Manganese Containing Superoxide Dismutase Protects Against Ochratoxin A-Induced Nephrotoxicity
Q64917297Structure-guided post-SELEX optimization of an ochratoxin A aptamer.
Q38711730Teratogenicity of Ochratoxin A and the Degradation Product, Ochratoxin α, in the Zebrafish (Danio rerio) Embryo Model of Vertebrate Development
Q115948488The aspergillic acid biosynthetic gene cluster predicts neoaspergillic acid production in Aspergillus section Circumdati
Q93051810Toxicological and Medical Aspects of Aspergillus-Derived Mycotoxins Entering the Feed and Food Chain

Search more.